. 09/2014: Liguo's ChIP-exo methodology paper (MACE) is accepted to Nucleic Acids Research. MACE is recommended by Active Motif as the software solution for the company's new ChIP-exo kit and service.
. 09/2013: Deqiang will start his tenure-track assistant professor position. Job well done.
. 09/2013: Zheng's prostate cancer RNA-seq paper with Dr. Balk at Harvard is accepted to Molecular Cancer Research . Yuanxin's work on H3K79 Methylation with Dr. Shi is accepted to Cell.
. 08/2013: Zheng's DaPars 3'UTR Pan Cancer analysis paper is accepted in principle to Nature Communications; Liguo's RSeQC paper is ranked No. 15 in the Most-Cited Articles in Bioinformatics as of August 1, 2014.
. 08/2013: Three Collaboration CPRIT grants are funded: DNA methylation with Goodell lab, 3'UTR with Wagner lab and ZM11 with Shi lab.
. 08/2014: Kaifu's "super promoter" paper is under review in Nature Genetics.
. 06/2014: Deqiang's Dnmt3a/3b double KO paper (with the Goodell Lab) is accepted to Cell Stem Cell .
. 06/2014: Zheng's alternative splicing paper (with the Cooper Lab) is accepted to Molecular Cell .
. 02/2014: Deqiang and Hyun Jung's HSC LncRNA paper (with the Goodell Lab) is in revision in Cell Stem Cell.
. 02/2014: Zheng's collaborative work on alternative splicing in heart development is accepted to Nature Communications.
. 02/2014: Zheng's brain tumor 3'UTR regulator paper is accepted to Nature. This paper was initially rejected after review twice. We appealed twice with success and finally made it in the 3rd submission.
. 02/2014: Welcome our new postdoc Jianzhong Su and graduate student Xueqiu Lin.
. 02/2014: Deqiang's mouse HSC Aging Epigenomics paper is accepted in principle to Cell Stem Cell.
. 01/2014: Deqiang's Methodology paper for the detection of differential DNA Methylation (MOABS) is accepted to Genome Biology.
. 01/2014: Our collaborative work on Breast Cancer Epigenetics is accepted to Science Translational Medicine.
. 01/2014: Yuanxin and Zheng's ZM11 paper with Xiaobing Shi lab in MD Anderson is accepted to Nature. This work links transcription elongation to tumor suppression.
. 12/2013: Kaifu's aging nucleosome paper is accepted to Genes & Development
. 12/2013: We received a 5-year NIH/NHGRI R01 grant (scored at 6 percentile in its first submission) to study DNA Methylation
. 11/2013: Wei will serve on the Editorial Board of Molecular Endocrinology
. 09/2013: Deqiang's DNA methylation Canyon paper is accepted to Nature Genetics.
. 09/2013: Xueqiu's bisulfite sequencing quality control paper (BSeQC) is accepted to Bioinformatics.
. 08/2013: Kadir's p53 paper is accepted to Nucleic Acids Research